Turning Biologic Innovation Into Commercial Success: Boehringer Ingelheim’s Expertise in Microbial Technology

This webcast features: Athelney Woolnough, Director Business Development/Key Account Management BioXcellence, Franz Schuster, Strategy Implementation Manager Biopharma Austria, Nikolaus Hammerschmidt, PhD, Head of Unit Downstream Development , Process Science, RCV, Boehringer Ingelheim.

Boehringer Ingelheim BioXcellence™ offers comprehensive support for successful development and manufacturing, treating customers’ products as if they were their own. Their expertise spans both mammalian cell culture and microbial fermentation technologies. The microbial product landscape, a specialty market, demands a variety of manufacturing process formats to cater to different molecule formats.

Their unique strength lies in the combination of their extensive commercial expertise and development capabilities. This enables them to provide the complete value chain, from early stages to launch and commercial supplies, for microbial derived biopharmaceuticals.

Discover how they can help drive your biologic breakthroughs towards a healthier future.